NSG-3250 EXAM 4 Questions With Correct Answers
// // // // // //
Spirochete: //Treponema //pallidum
syphilis
• //A //painless //lesion, //a //chancre, //develops //on //the //genitals
• //The //chancre //may //be //present //for //up //to //3-12 //weeks
2-3 //weeks //after //exposure
Primary //stage //of //syphilis
• //A //rash //develops //on //the //trunk //and //extremities //(hands //andfeet)
• //Contact //with //lesions //can //cause //spread //of //infection
• //Other //s/s //include: //arthritis, //meningitis, //fever, //malaise,and //weight //loss
Secondary //stage //of //syphilis
causes //progressive //inflammatory //changeswhich //can //impact //multiple //organ
•/
/Manifestations //include: //aortitis //and //neurosyphilis(dementia, //psychosis, //paresis, //stroke, //or
//meningitis)
Tertiary //stage //of //syphilis
Syphilis //management
,• //Antibiotics //are //the //primary //method //of //treatment
• //Penicillin //G //is //the //first //line //choice
• //If //allergic, //doxycycline //is //alternate
• //Most //common //in //women //15-24 //yrs //old
• //Often //asymptomatic• //s/s //include
• //Women: //purulent //discharge //in //the //endocervical //canal, //UTI //s/s, //and //vaginitis• //--
Men: /
/s/s //are //more //common, //burning //on //urination, //penile //discharge, //painful/swollen //testis
Chlamydia //and //gonorrhea
• //Flagellated //protozoan
• //Per //the //CDC, //about //3.7 //million //cases //per //year //inthe //US
• //Can //be //asymptomatic //which //increases //chancesof //spread
• //Increases //risk //for //HIV, //pregnancycomplications, //infertility, //and //PID
• //May //lead //to //cervical //cellular //changes
•/
/S/S /
/include: /
/malodorous /
/vaginal /
/discharge(may /
/be //frothy //and //discolored), //and //vulvitismay //occur //leading //to //burning //and //itching
Trichomoniasis
Metronidazole //or //Tinidazole //are
,treatments //for //trichomoniasis
HSV-1 //(genital //herpes)
PSA //levels //should //be //less //than
<4 //ng/mL
Dysuria //and //nocturia //and //high //levels //of //PSA //are //indications //of
Prostatitis, //BPH, //or //Prostate //cancer
Tamulosin
helps //improve //urine //flow
a/
/recurrent, /
/lifelong //viral //infection //that //has //the //potential //for //transmission //throughout //the //lifespan
Initial //infection //is //extremely //painful //and //lasts //2-4 //weeks
Genital //herpes
Non //cancerous //prostatic //enlargement
, BPH
prostate-specific //antigen //(PSA)
blood //test //that //measures //the //level //of //prostate-specific //antigen //in //the //blood
Tanulosin, //finasteride, //or //surgical //management //can //treat
BPH
epididymitis
inflammation /
/of /
/the /
/epididymis /
/that //is //frequently //caused //by //the //spread //of //infection //from //the //urethra //or //the //bladder
hydrocele
a //fluid-filled //sac //in //the //scrotum //along //the //spermatic //cord //leading //from //the //testicles
urethral //stricture
abnormal //narrowing //of //the //urethra
// // // // // //
Spirochete: //Treponema //pallidum
syphilis
• //A //painless //lesion, //a //chancre, //develops //on //the //genitals
• //The //chancre //may //be //present //for //up //to //3-12 //weeks
2-3 //weeks //after //exposure
Primary //stage //of //syphilis
• //A //rash //develops //on //the //trunk //and //extremities //(hands //andfeet)
• //Contact //with //lesions //can //cause //spread //of //infection
• //Other //s/s //include: //arthritis, //meningitis, //fever, //malaise,and //weight //loss
Secondary //stage //of //syphilis
causes //progressive //inflammatory //changeswhich //can //impact //multiple //organ
•/
/Manifestations //include: //aortitis //and //neurosyphilis(dementia, //psychosis, //paresis, //stroke, //or
//meningitis)
Tertiary //stage //of //syphilis
Syphilis //management
,• //Antibiotics //are //the //primary //method //of //treatment
• //Penicillin //G //is //the //first //line //choice
• //If //allergic, //doxycycline //is //alternate
• //Most //common //in //women //15-24 //yrs //old
• //Often //asymptomatic• //s/s //include
• //Women: //purulent //discharge //in //the //endocervical //canal, //UTI //s/s, //and //vaginitis• //--
Men: /
/s/s //are //more //common, //burning //on //urination, //penile //discharge, //painful/swollen //testis
Chlamydia //and //gonorrhea
• //Flagellated //protozoan
• //Per //the //CDC, //about //3.7 //million //cases //per //year //inthe //US
• //Can //be //asymptomatic //which //increases //chancesof //spread
• //Increases //risk //for //HIV, //pregnancycomplications, //infertility, //and //PID
• //May //lead //to //cervical //cellular //changes
•/
/S/S /
/include: /
/malodorous /
/vaginal /
/discharge(may /
/be //frothy //and //discolored), //and //vulvitismay //occur //leading //to //burning //and //itching
Trichomoniasis
Metronidazole //or //Tinidazole //are
,treatments //for //trichomoniasis
HSV-1 //(genital //herpes)
PSA //levels //should //be //less //than
<4 //ng/mL
Dysuria //and //nocturia //and //high //levels //of //PSA //are //indications //of
Prostatitis, //BPH, //or //Prostate //cancer
Tamulosin
helps //improve //urine //flow
a/
/recurrent, /
/lifelong //viral //infection //that //has //the //potential //for //transmission //throughout //the //lifespan
Initial //infection //is //extremely //painful //and //lasts //2-4 //weeks
Genital //herpes
Non //cancerous //prostatic //enlargement
, BPH
prostate-specific //antigen //(PSA)
blood //test //that //measures //the //level //of //prostate-specific //antigen //in //the //blood
Tanulosin, //finasteride, //or //surgical //management //can //treat
BPH
epididymitis
inflammation /
/of /
/the /
/epididymis /
/that //is //frequently //caused //by //the //spread //of //infection //from //the //urethra //or //the //bladder
hydrocele
a //fluid-filled //sac //in //the //scrotum //along //the //spermatic //cord //leading //from //the //testicles
urethral //stricture
abnormal //narrowing //of //the //urethra
